We are live on ! Find out more
SRTA

Strata Critical Medical Inc

122 hedge funds and large institutions have $184M invested in Strata Critical Medical Inc in 2024 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 41 increasing their positions, 34 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

365% more call options, than puts

Call options by funds: $1.63M | Put options by funds: $351K

52% more capital invested

Capital invested by funds: $121M → $184M (+$63M)

24% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 17

21% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 34

2.52% more ownership

Funds ownership: 52.85%55.37% (+2.5%)

2% more funds holding

Funds holding: 120122 (+2)

Holders
122
Holders Change
+2
Holders Change %
+1.67%
% of All Funds
1.61%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
41
Reduced
34
Closed
17
Calls
$1.63M
Puts
$351K
Net Calls
+$1.28M
Net Calls Change
+$1.05M
Name Holding Trade Value Shares
Change
Change in
Stake
AIM
1
ARK Investment Management
Florida
$34.2M +$3.17M +833,848 +12%
BlackRock
2
BlackRock
New York
$16.9M -$203K -53,360 -1%
Vanguard Group
3
Vanguard Group
Pennsylvania
$13.5M +$700K +183,941 +6%
Sumitomo Mitsui Trust Group
4
Sumitomo Mitsui Trust Group
Japan
$13.2M -$2.51M -659,089 -18%
NAMA
5
Nikko Asset Management Americas
New York
$13.1M -$2.48M -652,145 -17%
AIC
6
AWM Investment Company
New York
$11.8M
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$6.47M +$834K +218,985 +17%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$5.83M -$12.6K -3,318 -0.2%
State Street
9
State Street
Massachusetts
$5.41M -$29.3K -7,705 -0.6%
N
10
Nuveen
North Carolina
$4.6M +$1.3M +342,250 +46%
UIC
11
Uniplan Investment Counsel
Wisconsin
$4.14M -$260K -68,311 -7%
Citadel Advisors
12
Citadel Advisors
Florida
$4.01M +$2.94M +772,910 +452%
JP Morgan Chase
13
JP Morgan Chase
New York
$2.96M -$97.2K -25,543 -4%
Morgan Stanley
14
Morgan Stanley
New York
$2.89M +$1.1M +289,970 +74%
MHP
15
Manatuck Hill Partners
Connecticut
$2.55M +$2.28M +600,000 New
Russell Investments Group
16
Russell Investments Group
United Kingdom
$2.41M +$1.29M +338,103 +148%
First Eagle Investment Management
17
First Eagle Investment Management
New York
$2.28M +$2.04M +535,954 New
RA
18
Royce & Associates
New York
$2.09M +$1.87M +492,000 New
Northern Trust
19
Northern Trust
Illinois
$2.02M +$13.4K +3,532 +0.7%
Marshall Wace
20
Marshall Wace
United Kingdom
$1.92M +$1.36M +356,596 +372%
Renaissance Technologies
21
Renaissance Technologies
New York
$1.63M +$325K +85,486 +29%
JGC
22
J. Goldman & Co
New York
$1.61M -$322K -84,556 -18%
Goldman Sachs
23
Goldman Sachs
New York
$1.59M -$229K -60,024 -14%
TI
24
Tidal Investments
Wisconsin
$1.48M -$1.17M -308,224 -47%
GCP
25
GSA Capital Partners
United Kingdom
$1.33M -$246K -64,720 -17%

SRTA Hedge Fund Activity: Q4 2024 in Review

122 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc (SRTA) for Q4 2024, worth a combined $184M — up 52% from $121M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new SRTA positions and 17 closed out — a net gain of 4 holders — while 41 added to existing stakes and 34 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $3.17M. The largest seller was Sumitomo Mitsui Trust Group, cutting an estimated $2.51M.

  • 122 institutional investors held Strata Critical Medical Inc (SRTA) as of Q4 2024, up from 120 in Q3 2024.
  • Funds reported $184M of Strata Critical Medical Inc stock for Q4 2024, up 52% quarter-over-quarter.
  • 21 funds opened new Strata Critical Medical Inc positions in Q4 2024 and 17 closed out, a net change of +4 holders.
  • The largest Strata Critical Medical Inc buyer in Q4 2024 was ARK Investment Management, an estimated $3.17M added.
  • The largest Strata Critical Medical Inc seller in Q4 2024 was Sumitomo Mitsui Trust Group, an estimated $2.51M sold.

Based on aggregated 13F filings for Q4 2024.